This study found that a glycoprotein called CEACAM1 protects liver function after liver transplant. This is important because CEACAM1 mRNA expression can potentially be a marker of liver quality and eventual treatment outcomes, and an excellent example of how research performed by a lung scientist can have impact in other disease states and organ systems. Co-Author Xiaoyi Yuan, PhD was awarded the Lung Association Catalyst Award for her work evaluating mRNA as a therapeutic target for ARDS.
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank you! You will now receive email updates from the American Lung Association.